Research Article
Impact of Diabetes Mellitus on Early Clinical Outcome and Stent Restenosis after Carotid Artery Stenting
Table 1
Baseline characteristics in 1940 patients. PCI: percutaneous coronary intervention; CABG: coronary artery bypass grafting; PTA: percutaneous transluminal angioplasty; COPD: chronic obstructive pulmonary disease.
| | Nondiabetics | Diabetics | value | | () | () |
| | Age (years) | | | 0.14 | | Male sex | 547 (45%) | 353 (48%) | 0.17 | | Vascular risk factors | | | | | Hypertension | 42 (34%) | 283 (39%) | 0.03 | | Dyslipidemia | 211 (17%) | 136 (19%) | 0.50 | | Chronic dialysis | 114 (9%) | 78 (10%) | 0.36 | | Smoking | 281 (23%) | 159 (22%) | 0.46 | | Family history | 271 (22%) | 166 (23%) | 0.49 | | Previous PCI | 289 (24%) | 198 (27%) | 0.11 | | Previous CABG | 101 (8%) | 79 (11%) | 0.06 | | Previous carotid PTA | 75 (6%) | 59 (8%) | 0.11 | | Peripheral artery disease | 189 (15%) | 134 (18%) | 0.11 | | Atrial fibrillation | 233 (19%) | 134 (18%) | 0.40 | | COPD | 155 (12%) | 89 (12%) | 0.69 | | Degree of symptomatic carotid stenosis | | | | | 50–69% | 44 (15%) | 31 (16%) | 0.96 | | 70–99% | 251 (85%) | 175 (84%) | 0.96 | | Indication for stenting | | | | | Asymptomatic carotid stenosis | 843 (69%) | 480 (65%) | 0.06 | | Symptomatic carotid stenosis | 295 (24%) | 206 (28%) | 0.06 | | Acute carotid syndrome | 72 (7%) | 44 (7%) | 0.94 | | Procedural data | | | | | Radial access | 883 (72%) | 517 (70%) | 0.30 | | Femoral access | 281 (23%) | 188 (25%) | 0.20 | | Aortic arch type II/III | 553 (45%) | 312 (44%) | 0.20 | | Postdilatation | 1009 (83%) | 602 (84%) | 0.62 | | Predilatation | 321 (26%) | 201 (28%) | 0.62 | | Closed-cell stent (WALLSTENT®) | 784 (55%) | 499 (54%) | 0.10 | | Mesh-stent (Roadsaver ®) | 129 (11%) | 85 (12%) | 0.50 | | Length-of-stay, daysa | 5 (3-8) | 5 (3-9) | 0.43 |
|
|
aContinuous variables are summarized using medians and interquartile ranges (IQR).
|
